NEWSROOM

Perspectives on IP strategy, portfolio development, and the factors that shape how patents perform in practice. 

Life Sciences IP Strategy, Patent Strategy, Intellectual Property, Life Sciences IP, Artificial Intelligence Xinru Zhang Life Sciences IP Strategy, Patent Strategy, Intellectual Property, Life Sciences IP, Artificial Intelligence Xinru Zhang

If You Don’t Own the Data, You Don’t Own Anything.

In AI-enabled drug discovery, enterprise value depends on more than the pipeline. Data ownership, licensing terms, model improvements, and platform dependencies can shape IP strategy, diligence, and commercialization.

Read More